Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.


TSX:CPH - Post by User

Comment by PitchinPennieson Jan 15, 2021 9:01pm
201 Views
Post# 32312200

RE:RE:RE:RE:RE:Wow! Total incompetence!!!

RE:RE:RE:RE:RE:Wow! Total incompetence!!!How much time you got to go over all this? 

Cascading parade of increasingly mediocre-to-bad managers from Larry Andrews to Shawn Patrick O'Brien to, finally, a useless blithering idiot named Tessie. Lack of engagement by the bored-of-directors, notably Craig Mull. After Tessie drives the company to the brink, Craig basically fires all the employees and essentially ceases all operations for two years and he thinks no one will notice, while insisting that he's going to sell licenses to in-licensed drugs that he doesn't own. Meanwhile, no marketing of products, no product life-cycle management, no product detailing. And, lookee, lookee: now it's 2020 and here comes Covid, and Craig has no reaction to or recognition of the changed circumstances. Maybe he hasn't even heard about the pandemic. He is an oblivious clownish rich kid who has cost us money. A class-action suit sounds like the logical response.
<< Previous
Bullboard Posts
Next >>